Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

I Vergote, A Gonzalez-Martin, Domenico Lorusso, C Gourley, Mirza, Je Kurtz, A Okamoto, K Moore, F Kridelka, I Mcneish, A Reuss, B Votan, A du Bois, S Mahner, I Ray-Coquard, Ec Kohn, Js Berek, Dsp Tan, N Colombo, Ry ZangN Concin, D O'Donnell, A Rauh-Hain, Cs Herrington, C Marth, A Poveda, K Fujiwara, Gce Stuart, Am Oza, Ma Bookman, Sven Mahner, Alexander Reuss, Andreas du Bois, Christoph Grimm, Christian Marth, Regina Berger, Nicole Concin, Ting-Chang Chang, Kazunori Ochiai, Val Gebski, Alison Davis, Philip Beale, Ignace Vergote, Frédéric Kridelka, Hannelore Denys, Vincent Vandecaveye, Francisco Jose Candido dos Reis, Maria Del Pilar Estevez Diz, Gavin Stuart, Helen MacKay, Mark Carey, David Cibula, Pavel Dundr (path), Oliver Dorigo, Jonathan Berek, Dearbhaile O'Donnell, Abu Saadeh, Ingrid Boere, Christianne Lok, Pluvio Coronado, Nelleke Ottevanger, David SP Tan, Ng Joseph, Antonio Gonzalez Martin, Ana Oaknin, Andres Poveda, Alejandro Perez Fidalgo, Alejandro Rauh-Hain, Lu Karen, Carlos López-Zavala, Eva María Gómez-García, Isabelle Ray-Coquard, Xavier Paoletti, Jean-Emmanuel Kurtz, Florence Joly, Bénédicte Votan, Michael Bookman, Kathleen Moore, Rebecca Arend, Keiichi Fujiwara, Hiroyuki Fujiwara, Kosei Hasegawa, Ilan Bruchim, Dalia Tsoref, Katsutoshi Oda, Aikou Okamoto, Takayuki Enomoto, Dayana Michel, Hee-Seung Kim, Jung-Yun Lee, Asima Mukhopadhyay, Dionyssios Katsaros, Nicoletta Colombo, Sandro Pignata, Domenica Lorusso, Giovanni Scambia, Elise Kohn, Jung-Min Lee, Iain McNeish, Shibani Nicum, Laura Farrelly, Jalid Sehouli, Maren Keller, Elena Braicu, Line Bjørge, Mansoor Raza Mirza, Annika Auranen, Stephen Welch, M Oza Amit, Viola Heinzelmann, Charlie Gourley, Patricia Roxburgh, C Simon Herrington, Ros Glasspool, Rongyu Zang, Jianqing Zhu

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical Research was held virtually in October, 2021, following published consensus guidelines. The goal of the consensus meeting was to achieve harmonisation on the design elements of upcoming trials in ovarian cancer, to select important questions for future study, and to identify unmet needs. All 33 GCIG member groups participated in the development, refinement, and adoption of 20 statements within four topic groups on clinical research in ovarian cancer including first line treatment, recurrent disease, disease subgroups, and future trials. Unanimous consensus was obtained for 14 of 20 statements, with greater than 90% concordance in the remaining six statements. The high acceptance rate following active deliberation among the GCIG groups confirmed that a consensus process could be applied in a virtual setting. Together with detailed categorisation of unmet needs, these consensus statements will promote the harmonisation of international clinical research in ovarian cancer.
Lingua originaleEnglish
pagine (da-a)E374-E384
RivistaThe Lancet Oncology
Volume23
DOI
Stato di pubblicazionePubblicato - 2022

Keywords

  • n/a

Fingerprint

Entra nei temi di ricerca di 'Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup'. Insieme formano una fingerprint unica.

Cita questo